Hydroxychloroquine - An Antimalarial and Anti-inflammatory Drug
DOI:
https://doi.org/10.59793/ijcp.v24i4.963Keywords:
Hydroxychloroquine,, T2DM,, DMARD,, antimalarial,, diabetesAbstract
Hydroxychloroquine – a quinoline antimalarial, has hypoglycemic effects that manifest due to
its action on the intracellular insulin metabolism in peripheral tissues. Recent studies confirm
that the use of Hydroxychloroquine can aid in preventing new onset diabetes and complications
of diabetes, systemic lupus erythematosus and rheumatoid arthritis, as well as in improving
the mortality rate of these patients
Downloads
Published
Issue
Section
License
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.
How to Cite
